Injective (INJ) is currently trading at $3.24, showing a 1.80% increase over the last 24 hours, reflecting stable bullish sentiment. The price has fluctuated within a daily range of $3.17 to $3.34, indicating a relatively tight trading range amidst moderate volume of approximately 49.68 million.

The hourly moving averages are mixed, with the 55 SMA and 144 SMA indicating positive momentum (+2.82% and +5.18%, respectively), while shorter-term SMAs are showing slight declines. The 1-hour RSI stands at 53, suggesting a neutral trend, while the 7-day RSI at 58 indicates increasing strength, and the 7-day price change is notably positive at 9.01%.

Despite a minor negative shift in the 30-day price change (-0.21%), the recent upward movements in both short and medium-term indicators signal resilience. Additionally, the volume-to-market cap ratio of 15.33% suggests active trading, which often correlates with price stability and potential future gains.

Considering the all-time high of $52.62 reached in March 2024, current price levels represent a significant discount and suggest room for growth. The fundamentals indicate a strong underlying project, and the recent price activity supports a potential upward trend.

Given the mixed moving averages, positive RSI signals, and strong trading volume, a Buy rating is warranted. Investors should consider entering positions to capitalize on potential upward momentum, especially with the favorable market conditions observed over the past week.